WBA stock forecast
Our latest prediction for Walgreens Boots Alliance, Inc.'s stock price was made on the July 16, 2018 when the stock price was at 65.16$.
In the short term (2weeks), WBA's stock price should outperform the market by 1.51%. During that period the price should oscillate between -3.35% and +3.57%.
In the medium term (3months), WBA's stock price should outperform the market by 0.46%. During that period the price should oscillate between -8.84% and +10.20%.Get email alerts
Create a solid portfolio with WBA
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.
At the moment the company generates 136866M USD in revenues.
On its last earning announcement, the company reported a profit of 4.30$ per share.
The book value per share is 27.95$
Three months stock forecastJuly 16, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|